A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Elias Jabbour Susan O'Brien Zeev Estrov Guillermo Garcia-Manero Srdan Verstovsek Jorge Eduardo Cortes Hagop Kantarjian Stefan Faderl Farhad Ravandi |
| Publication date | October 19, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |